Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Duffy

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Health Affairs (Project Hope)|January 5, 2021
Arbitration Over Out-Of-Network Medical Bills: Evidence From New Jersey Payment DisputesBenjamin L Chartock, Loren Adler, Bich Ly, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomalleiSandra McCurdy, Erin Duffy, Mark Hickman, et al.
Health Affairs (Project Hope)|January 18, 2023
Ground Ambulance Billing And Prices Differ By Ownership StructureLoren Adler, Bich Ly, Erin Duffy, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2016
In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin ResistanceOlusegun O Soge, Stephen J Salipante, David No, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|December 12, 2018
Delivery of Preventive Oral Health Services by Rurality: A Cross-Sectional AnalysisCaroline K Geiger, Ashley M Kranz, Andrew W Dick, et al.
Maternal and Child Health Journal|July 23, 2018
Impact of Medicaid Policy on the Oral Health of Publicly Insured ChildrenAshley M Kranz, Erin Duffy, Andrew W Dick, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycinJeff Kingsley, Purvi Mehra, Laura E Lawrence, et al.
Rheumatology (Oxford, England)|February 19, 2016
Performance of Gout Impact Scale in a longitudinal observational study of patients with goutBeth Wallace, Dinesh Khanna, Cleopatra Aquino-Beaton, et al.
The Lancet. Infectious Diseases|September 19, 2025
Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discoveryAlex Howard, Nada Reza, Peter L Green, et al.
Rheumatology (Oxford, England)|August 29, 2015
Elevated baseline power Doppler discriminates an RA subgroup highly responsive to therapyVeena K Ranganath, Ami Ben-Artzi, Erin Duffy, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Health Affairs (Project Hope)|January 5, 2021
Arbitration Over Out-Of-Network Medical Bills: Evidence From New Jersey Payment DisputesBenjamin L Chartock, Loren Adler, Bich Ly, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomalleiSandra McCurdy, Erin Duffy, Mark Hickman, et al.
Health Affairs (Project Hope)|January 18, 2023
Ground Ambulance Billing And Prices Differ By Ownership StructureLoren Adler, Bich Ly, Erin Duffy, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2016
In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin ResistanceOlusegun O Soge, Stephen J Salipante, David No, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|December 12, 2018
Delivery of Preventive Oral Health Services by Rurality: A Cross-Sectional AnalysisCaroline K Geiger, Ashley M Kranz, Andrew W Dick, et al.
Maternal and Child Health Journal|July 23, 2018
Impact of Medicaid Policy on the Oral Health of Publicly Insured ChildrenAshley M Kranz, Erin Duffy, Andrew W Dick, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycinJeff Kingsley, Purvi Mehra, Laura E Lawrence, et al.
Rheumatology (Oxford, England)|February 19, 2016
Performance of Gout Impact Scale in a longitudinal observational study of patients with goutBeth Wallace, Dinesh Khanna, Cleopatra Aquino-Beaton, et al.
The Lancet. Infectious Diseases|September 19, 2025
Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discoveryAlex Howard, Nada Reza, Peter L Green, et al.
Rheumatology (Oxford, England)|August 29, 2015
Elevated baseline power Doppler discriminates an RA subgroup highly responsive to therapyVeena K Ranganath, Ami Ben-Artzi, Erin Duffy, et al.
Pageof 4